Document Detail


Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitors.
MedLine Citation:
PMID:  16979339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A novel 4-aminopyrimidine-5-carboxaldehyde oxime scaffold with inhibitory activity against VEGFR-2 kinase has been identified. With a 4-fluoro-2-methylindol-5-yloxy group at the 6-position and alkyl groups as the oxime side chains, many analogues showed good potency for VEGFR-2. This series also exhibited antiproliferative activity against cancer cells, causing cell accumulation at the G2/M phase of the cell cycle and preventing cells from entering mitosis. Described here are the chemistry, structure-activity relationships (SAR), and biological testing for this series.
Authors:
Shenlin Huang; Ronghua Li; Peter J Connolly; Guozhang Xu; Michael D Gaul; Stuart L Emanuel; Kenneth R Lamontagne; Lee M Greenberger
Related Documents :
7251649 - Cell population heterogeneity in the inducibility of dna synthesis in human diploid fib...
15138059 - Use of a human-derived liver cell line for the detection of cytoprotective, antigenotox...
21278009 - Tracking biological cells in time-lapse microscopy: an adaptive technique combining mot...
22627279 - Gut endoderm is involved in the transfer of left-right asymmetry from the node to the l...
5474879 - Inhibition of carotenoid hydroxylation in staphylococcus aureus by mixed-function oxida...
7860599 - Digital image analysis of growth and starvation responses of a surface-colonizing acine...
20063389 - Development and optimization of a process for automated recovery of single cells identi...
18042259 - Baculovirus-mediated immediate-early gene expression and nuclear reorganization in huma...
5271169 - Effects of cytochalasin b upon microfilaments involved in morphogenesis of salivary epi...
Publication Detail:
Type:  Journal Article     Date:  2006-09-18
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  16     ISSN:  0960-894X     ISO Abbreviation:  Bioorg. Med. Chem. Lett.     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2006-11-10     Completed Date:  2007-01-08     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  England    
Other Details:
Languages:  eng     Pagination:  6063-6     Citation Subset:  IM    
Affiliation:
Johnson and Johnson Pharmaceutical Research and Development, L.L.C, 1000 Route 202, Raritan, NJ 08869, USA. shenlinhuang@hotmail.com <shenlinhuang@hotmail.com>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Proliferation / drug effects
Hela Cells
Humans
Molecular Structure
Oximes / chemical synthesis,  chemistry*,  pharmacology*
Protein Kinase Inhibitors / chemical synthesis*,  chemistry,  pharmacology*
Pyrimidines / chemical synthesis*,  pharmacology*
Structure-Activity Relationship
Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*,  metabolism
Chemical
Reg. No./Substance:
0/Oximes; 0/Protein Kinase Inhibitors; 0/Pyrimidines; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopy...
Next Document:  Enzyme inhibition potency enhancement by active site metal chelating and hydrogen bonding induced co...